WAGNER CHARLES F JR 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Jan 8, 2026
Insider Transaction Report
Form 4
WAGNER CHARLES F JR
EVP, CO & FO
Transactions
- Exercise/Conversion
Common Stock
2026-01-06$189.38/sh+9,532$1,805,170→ 47,257 total - Sale
Common Stock
2026-01-06$461.00/sh−9,532$4,394,252→ 37,725 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-06−9,532→ 0 totalExercise: $189.38Exp: 2029-04-09→ Common Stock (9,532 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 5/09/2025.
- [F2]Fully vested.